The ground-breaking PRECISION-Panc project aims to speed up scientific discovery to improve the survival rates of patients with pancreatic cancer. In this interview at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK, Derek Grose, MBChB, MRCP, FRCR, MD of the Beatson West of Scotland Cancer Centre, Glasgow, UK provides an overview of the project, including its aims, work and exciting recent publications on the discovery of pancreatic adenocarcinoma subtypes. He highlights how this project has the potential to improve the time scale of testing, thus providing clinically applicable results, such as those from whole genome sequencing, and improving the outlook of pancreatic cancer patients.
The PRECISION-Panc project: Speeding up scientific discovery to improve pancreatic cancer patient survival
